nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—ABCB1—peripheral nervous system neoplasm	0.368	1	CbGaD
Mebendazole—TUBB4B—Vincristine—peripheral nervous system neoplasm	0.206	0.365	CbGbCtD
Mebendazole—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0816	0.145	CbGbCtD
Mebendazole—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0702	0.125	CbGbCtD
Mebendazole—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0343	0.0609	CbGbCtD
Mebendazole—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0343	0.0609	CbGbCtD
Mebendazole—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0238	0.0422	CbGbCtD
Mebendazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0205	0.0365	CbGbCtD
Mebendazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0191	0.0339	CbGbCtD
Mebendazole—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0146	0.026	CbGbCtD
Mebendazole—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0137	0.0243	CbGbCtD
Mebendazole—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0134	0.0238	CbGbCtD
Mebendazole—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00915	0.0163	CbGbCtD
Mebendazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00877	0.0156	CbGbCtD
Mebendazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00804	0.0143	CbGbCtD
Mebendazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00548	0.00974	CbGbCtD
Mebendazole—Prolonged menses—Vincristine—peripheral nervous system neoplasm	0.00539	0.125	CcSEcCtD
Mebendazole—TUBA1A—pons—peripheral nervous system neoplasm	0.00524	0.293	CbGeAlD
Mebendazole—TUBA1A—nerve—peripheral nervous system neoplasm	0.00272	0.152	CbGeAlD
Mebendazole—TUBA1A—ganglion—peripheral nervous system neoplasm	0.00268	0.15	CbGeAlD
Mebendazole—Menorrhagia—Vincristine—peripheral nervous system neoplasm	0.00153	0.0354	CcSEcCtD
Mebendazole—TUBA1A—trigeminal ganglion—peripheral nervous system neoplasm	0.00132	0.0738	CbGeAlD
Mebendazole—TUBA1A—parotid gland—peripheral nervous system neoplasm	0.00124	0.0696	CbGeAlD
Mebendazole—TUBA1A—brainstem—peripheral nervous system neoplasm	0.00117	0.0653	CbGeAlD
Mebendazole—TUBA1A—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.151	CbGdCrCtD
Mebendazole—TUBA1A—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.00106	0.151	CbGdCrCtD
Mebendazole—Neutropenia—Topotecan—peripheral nervous system neoplasm	0.000915	0.0212	CcSEcCtD
Mebendazole—Neutropenia—Isotretinoin—peripheral nervous system neoplasm	0.000908	0.021	CcSEcCtD
Mebendazole—Neutropenia—Tretinoin—peripheral nervous system neoplasm	0.000908	0.021	CcSEcCtD
Mebendazole—Neutropenia—Melphalan—peripheral nervous system neoplasm	0.000896	0.0207	CcSEcCtD
Mebendazole—TUBB4B—trigeminal ganglion—peripheral nervous system neoplasm	0.000879	0.0492	CbGeAlD
Mebendazole—Albendazole—ABCB1—peripheral nervous system neoplasm	0.000876	1	CrCbGaD
Mebendazole—TUBB4B—parotid gland—peripheral nervous system neoplasm	0.000829	0.0464	CbGeAlD
Mebendazole—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.000808	0.0187	CcSEcCtD
Mebendazole—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.000808	0.0187	CcSEcCtD
Mebendazole—TUBA1A—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000805	0.115	CbGdCrCtD
Mebendazole—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.000777	0.018	CcSEcCtD
Mebendazole—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.000777	0.018	CcSEcCtD
Mebendazole—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.000767	0.0178	CcSEcCtD
Mebendazole—TUBA1A—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000742	0.106	CbGdCrCtD
Mebendazole—TUBA1A—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000742	0.106	CbGdCrCtD
Mebendazole—TUBA1A—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000742	0.106	CbGdCrCtD
Mebendazole—TUBA1A—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000742	0.106	CbGdCrCtD
Mebendazole—Neutropenia—Dactinomycin—peripheral nervous system neoplasm	0.000742	0.0172	CcSEcCtD
Mebendazole—Neutropenia—Alitretinoin—peripheral nervous system neoplasm	0.000688	0.0159	CcSEcCtD
Mebendazole—Neutropenia—Vincristine—peripheral nervous system neoplasm	0.000663	0.0154	CcSEcCtD
Mebendazole—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00066	0.0153	CcSEcCtD
Mebendazole—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.000635	0.0147	CcSEcCtD
Mebendazole—Angioedema—Topotecan—peripheral nervous system neoplasm	0.000623	0.0144	CcSEcCtD
Mebendazole—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.000612	0.0142	CcSEcCtD
Mebendazole—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.000589	0.0136	CcSEcCtD
Mebendazole—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000586	0.0136	CcSEcCtD
Mebendazole—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000586	0.0136	CcSEcCtD
Mebendazole—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000579	0.0134	CcSEcCtD
Mebendazole—TUBA1A—cerebellum—peripheral nervous system neoplasm	0.000575	0.0322	CbGeAlD
Mebendazole—TUBA1A—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.0801	CbGdCrCtD
Mebendazole—TUBA1A—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.0801	CbGdCrCtD
Mebendazole—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.000537	0.0124	CcSEcCtD
Mebendazole—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000478	0.0111	CcSEcCtD
Mebendazole—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000464	0.026	CbGeAlD
Mebendazole—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000455	0.0105	CcSEcCtD
Mebendazole—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000452	0.0105	CcSEcCtD
Mebendazole—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000452	0.0105	CcSEcCtD
Mebendazole—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000444	0.0103	CcSEcCtD
Mebendazole—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000442	0.0102	CcSEcCtD
Mebendazole—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00044	0.0102	CcSEcCtD
Mebendazole—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000439	0.0102	CcSEcCtD
Mebendazole—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000439	0.0102	CcSEcCtD
Mebendazole—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000437	0.0101	CcSEcCtD
Mebendazole—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000437	0.0101	CcSEcCtD
Mebendazole—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000433	0.01	CcSEcCtD
Mebendazole—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000428	0.00991	CcSEcCtD
Mebendazole—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00041	0.00949	CcSEcCtD
Mebendazole—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000407	0.00942	CcSEcCtD
Mebendazole—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000407	0.00942	CcSEcCtD
Mebendazole—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000402	0.0093	CcSEcCtD
Mebendazole—TUBB4B—cerebellum—peripheral nervous system neoplasm	0.000384	0.0215	CbGeAlD
Mebendazole—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000379	0.00876	CcSEcCtD
Mebendazole—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000369	0.00854	CcSEcCtD
Mebendazole—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000357	0.00826	CcSEcCtD
Mebendazole—Rash—Topotecan—peripheral nervous system neoplasm	0.000351	0.00813	CcSEcCtD
Mebendazole—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000351	0.00812	CcSEcCtD
Mebendazole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000348	0.00806	CcSEcCtD
Mebendazole—Rash—Tretinoin—peripheral nervous system neoplasm	0.000348	0.00806	CcSEcCtD
Mebendazole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000348	0.00805	CcSEcCtD
Mebendazole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000348	0.00805	CcSEcCtD
Mebendazole—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000347	0.00803	CcSEcCtD
Mebendazole—Rash—Melphalan—peripheral nervous system neoplasm	0.000344	0.00796	CcSEcCtD
Mebendazole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000343	0.00795	CcSEcCtD
Mebendazole—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00792	CcSEcCtD
Mebendazole—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000333	0.0077	CcSEcCtD
Mebendazole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.0077	CcSEcCtD
Mebendazole—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00766	CcSEcCtD
Mebendazole—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00033	0.00763	CcSEcCtD
Mebendazole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000319	0.00738	CcSEcCtD
Mebendazole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00714	CcSEcCtD
Mebendazole—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00697	CcSEcCtD
Mebendazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000297	0.00688	CcSEcCtD
Mebendazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.00659	CcSEcCtD
Mebendazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.00645	CcSEcCtD
Mebendazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000268	0.0062	CcSEcCtD
Mebendazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000267	0.00618	CcSEcCtD
Mebendazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.00611	CcSEcCtD
Mebendazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.0061	CcSEcCtD
Mebendazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00608	CcSEcCtD
Mebendazole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00026	0.00601	CcSEcCtD
Mebendazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000258	0.00598	CcSEcCtD
Mebendazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00597	CcSEcCtD
Mebendazole—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000256	0.0143	CbGeAlD
Mebendazole—Rash—Vincristine—peripheral nervous system neoplasm	0.000254	0.00589	CcSEcCtD
Mebendazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000254	0.00588	CcSEcCtD
Mebendazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00574	CcSEcCtD
Mebendazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000241	0.00557	CcSEcCtD
Mebendazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.00552	CcSEcCtD
Mebendazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000225	0.0052	CcSEcCtD
Mebendazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000225	0.0052	CcSEcCtD
Mebendazole—Rash—Etoposide—peripheral nervous system neoplasm	0.000206	0.00477	CcSEcCtD
Mebendazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000206	0.00476	CcSEcCtD
Mebendazole—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000194	0.0045	CcSEcCtD
Mebendazole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00416	CcSEcCtD
Mebendazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00347	CcSEcCtD
Mebendazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00337	CcSEcCtD
Mebendazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00335	CcSEcCtD
Mebendazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00321	CcSEcCtD
Mebendazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00312	CcSEcCtD
Mebendazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00312	CcSEcCtD
Mebendazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.0031	CcSEcCtD
Mebendazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00289	CcSEcCtD
Mebendazole—Rash—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00267	CcSEcCtD
Mebendazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00267	CcSEcCtD
Mebendazole—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000112	0.00624	CbGeAlD
Mebendazole—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00247	CcSEcCtD
Mebendazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00247	CcSEcCtD
